Employment
|
|
Higher Education
- PhD in Medicine, University College Dublin, Ireland. 2007-2011
- Master of Science, Biomedical Research School, Linköping University, Sweden. 2006-2007
- Master of Science, Medical Biology Program, Linköping University, Sweden. 2006-2007
- Bachelor of Science, Medical Biology Program, Linköping University, Sweden. 2003-2006
Scientific Mentors
- Catherine Godson, Professor of Molecular Medicine, University College Dublin, Ireland.
- Kumar Sharma, Professor of Medicine University of California San Diego, USA.
Awards and Honors
- Junior Investigator Award, International Conference on Phospholipase A2 and Lipid Mediators, San Diego. 2016
- Emerging Leaders in Nutritional Sciences, Experimental Biology, San Diego. 2016
- Nominated for the Hasselblad Foundation Award for women scientists, Sweden. 2015
- Highlighted poster, Bioactive Lipids in Inflammation & Diseases, Puerto Rico. 2013
- Nominated for Roche National Researcher of the Year, Ireland. 2013
- Honorary Directors Prize due to special distinction, UCD Conway festival, Ireland. 2013
- Best moderated poster, Diabetes & Vascular biology, UCD Conway festival, Ireland. 2013
- Best scientific presentation, Irish Society of Nephrology, Ireland. 2013
- Outstanding junior career progression, ERA-EDTA ‘Molecular Targets in Renal Disease’ Symposia, Germany. 2011
Professional Memberships
- Swedish Society of Obesity Research.
- American Society of Nephrology.
Publications
Original Peer-Reviewed Publications
- Börgeson E, Wallenius V, Syed GH, Darshi M, Lantero Rodriguez J, Biörserud C, Ragnmark Ek M, Björklund P, Quiding-Järbrink M, Fändriks L, Godson C, Sharma K. AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin. Diabetologia. 2017; 60(4):729-739. PMID: 28188334 Weblink.
- Zhong L, Ding Y, Bandyopadhyay G, Waaler J, Börgeson E, Smith S, Phillips S, Mahooti S, Mahata S, Shao J, Krauss S, Chi N-W. The PARsylation activity of tankyrase in adipose tissue modulates systemic glucose homeostasis in mice, Diabetologia, 2016 Mar;59(3):582-91, PMID: 26631215. Weblink.
- Börgeson E*, Johnsson A, Lee Y.S., Till A, Syed H, Ali-Shah, Guiry P, Dalli D, Colas R, Serhan CN, Godson C, Sharma K. Lipoxin A4 attenuates obesity-induced adipose inflammation, liver and kidney disease. Cell Metabolism 2015 Jul 7;22(1):125-37, PMID:26052006. *Corresponding author. Weblink.
- Corcoran JB, McCarthy, Griffin B, Gaffney A, Bhreathnach U, Börgeson E, Hickey FB, Docherty NG, Higgins DF, Furlong F, Martin F, Godson C, Murphy M. IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013 Aug;1833(8):1969-78, PMID: 23567938. Weblink.
- Brennan EP, Nolan KA, Börgeson E, Gough OS, McEvoy CM, Docherty NG, Higgins DF, Murphy M, Sadlier DM, Ali-Shah ST, Guiry PJ, Savage DA, Maxwell AP, Martin F, Godson C. Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1. Journal of the American Society of Nephrology, 2013 Mar;24(4):627-37, PMID: 23520204. Weblink.
- Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C. Lipoxin A4 attenuates adipose inflammation. FASEB Journal. 2012 Oct;26(10):4287-94, PMID: 22700871. Weblink.
- Börgeson E, Docherty NG, Murphy M, Rodgers K, Ryan A, O'Sullivan TP, Guiry PJ, Goldschmeding R, Higgins DF, Godson C Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis. FASEB Journal. 2011 Sep;25(9):2967-79. PMID: 21628447. Weblink.
- Börgeson E, Lönn J, Bergström I, Brodin VP, Ramström S, Nayeri F, Särndahl E, Bengtsson T. Lipoxin A4 inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression. Infection and Immunity 2011 Apr;79(4):1489-97, PMID: 21263017. Weblink.
Peer-Reviewed Review Articles
- Börgeson E.* The role of lipoxins in cardiometabolic physiology and disease. Cardiovascular Endocrinology Journal, November 2015. *Corresponding author. Invited review article. Weblink.
- Börgeson E, Sharma K. Obesity, immunomodulation and chronic kidney disease. Current Opinion in Pharmacol. 2013 Aug;13(4):618-24. PMID: 23751262. Invited review article. Weblink.
- Börgeson E, Godson C. Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Frontiers in Immunology, 2012 Oct 18;3:318, PMID: 23087692. Invited review article. Weblink.
- Börgeson E, Godson C. Molecular circuits of resolution in renal disease. The Scientific World Journal. 2010 Jul 7;10:1370-85, PMID: 20623097. Invited review article. Weblink.
For a full list of publications, please see: https://www.ncbi.nlm.nih.gov/sites/myncbi/1t3r-m5jerA5-/bibliography/47065957/public/?sort=date&direction=ascending
